+ Follow RIVASTIGMINE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 211813
[Title] => Cholinesterase inhibitors: The earlier, the better
[Summary] => Cholinesterase inhibitor treatment should be started as early as possible in the course of dementia and continued as long as the perception of benefit outweighs the cost and side-effect profile. Decisions about which cholinesterase inhibitors to use in which patients, when to start using them, and whether to stop using them are "empirical", based on negotiation between the patient, physician, and family. They offered his recommendations based on the published data and common practice of dementia specialists in the United States and Europe.
[DatePublished] => 2003-06-29 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
RIVASTIGMINE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 211813
[Title] => Cholinesterase inhibitors: The earlier, the better
[Summary] => Cholinesterase inhibitor treatment should be started as early as possible in the course of dementia and continued as long as the perception of benefit outweighs the cost and side-effect profile. Decisions about which cholinesterase inhibitors to use in which patients, when to start using them, and whether to stop using them are "empirical", based on negotiation between the patient, physician, and family. They offered his recommendations based on the published data and common practice of dementia specialists in the United States and Europe.
[DatePublished] => 2003-06-29 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest